The Asia Pacific Biopsy Devices Market would witness market growth of 8.6% CAGR during the forecast period (2022-2028).
It is anticipated that the market growth will boost by the demand for disposable biopsy devices and less invasive operations. Vacuum-assisted guns are a scientifically advanced biopsy guidance system that is gaining approval from patients and doctors. In addition, the elderly population all over the world is increasing, rising the risk of chronic diseases such as cancer.
An increase in cancer-related expenditure is causing the necessity for effective analytic measures. Regulatory bodies of administration and hospitals worldwide are always involved in decreasing costs related to cancer treatments. Primary and secondary hospitals in developing countries inspire patients to undergo consistent analytical tests.
Using biopsy devices is economically feasible as it means a decrease in the number of days staying in the hospital. Some biopsy tools enable precise positioning of the central stylet and its sample notch before firing the cutting sheath over the stylet. As a result, the needle does not move forward again after firing the gun, minimising potential harm to nearby structures. This is helpful when the lesion is tiny or when it is close to vital organs or veins.
China is among the flourishing healthcare sectors in the world and offers potential for the American exporters in numerous secondary healthcare sectors. The medical equipment of the healthcare sector continues to be the most active and vitally essential segment for international enterprises. By 2028, it is anticipated that Malaysia's healthcare spending will be doubled to USD 2.8 billion.
The China market dominated the Asia Pacific Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $225.6 million by 2028.The Japan market is estimated to grow a CAGR of 7.9% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.2% during (2022 - 2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End User, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Biopsy Devices Market is Projected to reach USD 3 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
